国有企业技术创新能力低下的成因探析

被引:5
作者
秦宪文
机构
[1] 山东经济学院山东济南
关键词
企业技术创新能力; 投资; 不确定性; 金融; 财政管理; 财政金融; 技术创新; 委托代理制;
D O I
10.14110/j.cnki.cn-37-1059/d.2002.04.027
中图分类号
F276.1 [国有企业经济];
学科分类号
摘要
引用
收藏
页码:73 / 74
页数:2
相关论文
共 5 条
  • [1] Chemotherapeutic inhibitors in the treatment of prostate cancer
    Deshmukh, Rahul R.
    Schmitt, Sara M.
    Hwang, Clara
    Dou, Qing Ping
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) : 11 - 22
  • [2] Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma. Peng Bo,Gu Yixue,Xiong Yan,Zheng Guopei,He Zhimin. PloS one . 2012
  • [3] Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells. Yamano Yukio,Shiiba Masashi,Negoro Kenji,Nakatani Ken,Kasamatsu Atsushi,Yamatoji Masanobu,Sakuma Kentaro,Ogoshi Kenji,Iyoda Manabu,Shinozuka Keiji,Yokoe Hidetaka,Wada Takeshi,Fujita Shigeyuki,Iwasawa Shunichiro,Takiguchi Yuichi,Tanzawa Hide. Head and Neck . 2010
  • [4] Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases[J] . Mario Pérez-Sayáns,José Manuel Somoza-Martín,Francisco Barros-Angueira,Pilar Gayoso Diz,José Manuel Gándara Rey,Abel García-García. &nbspCancer Letters . 2010 (2)
  • [5] Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance[J] . Hariharan Easwaran,Hsing-Chen Tsai,Stephen B. Baylin. &nbspMolecular Cell . 2014 (5)